Search results for: 'pain 1'

15 Oct 2024  |  Global  |  Technology Research

Emerging Non-opioid Treatments for Pain Management

Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

Infographics

×

The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

Over the past several decades drug therapies such as analgesics, NSAIDs, and opioids have been used for the effective treatment of different types of acute, chronic, and injury-related pain. Dependence on these drug therapies have led to multiple side effects in human bodies and also addiction towards its consumption. Considering the direct and ind...

Like most industries in 2024, technological advances, shifting consumer preferences, and regulatory changes are transforming the global automotive industry. Frost & Sullivan’s analysis shows that Chinese Tier 1 suppliers have emerged as pivotal players in this dynamic environment, leveraging their technological capabilities and innovative prowess t...

The Microelectronics Technology Opportunity Engine covers innovations pertaining to Sub-1 Nm Chip technology, MMIC, SOC, Photonic Chiplet, GaN and Power Electronics among others.The Microelectronics Technology Opportunity Engine captures global electronics-related innovations and developments on a weekly basis. Developments are centered on electron...

The rapid adoption of GLP-1 therapies is reshaping the weight management landscape and creating a new set of nutritional needs among consumers using these treatments. While GLP-1 therapies have demonstrated significant benefits for weight loss and metabolic health, associated challenges—including reduced appetite and food intake, loss of lean muscl...

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gen...

15 Apr 2025  |  Global  |  Market Research

Class 1–3 Engine Management Sensors Aftermarket, Europe, 2024–2029

Disruptive Technologies and Stricter Regulations are Driving Transformational Growth by Increasing the Number of Sensor-equipped Vehicles as well as the Number of Sensors Per Vehicle

Infographics

×

This Frost & Sullivan report analyzes the transformative shifts affecting the Class 1–3 engine management sensors (EMS) aftermarket in Europe for passenger cars and light commercial vehicles. The report categorizes EMS as follows: Camshaft/crankshaft sensors, manifold absolute pressure sensors, anti-lock brake system sensors, mass air flow sensors,...

Weight management is a growing area of interest in the nutraceutical industry, driven by rising obesity rates and increasing consumer demand for natural health solutions.Nutraceutical ingredients used in weight management include a diverse range of bioactive compounds that support fat metabolism, appetite regulation, thermogenesis, and glycemic con...